STADA ARZNEIMITTEL AG

Italy

All drugs from this manufacturer

  • HUKYNDRA

    Hukyndra is indicated for the treatment of several inflammatory diseases, including rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitis-associated arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, non-infectious uveitis, and hidradenitis suppurativa.

    Dosage form: solution for injection

    Active substance Dosage
    adalimumab -

    ATC: L04AB04

  • It is used for the treatment of primary IgA nephropathy in adults aged 18 and older, acting on the intestine to reduce inflammation.

    Dosage form: capsules, modified release, hard

    Active substance Dosage
    budesonide -

    ATC: A07EA06

  • It is used to treat osteoporosis in adults, with the aim of making bones stronger and reducing the risk of fractures by stimulating their rebuilding.

    Dosage form: solution for injection

    Active substance Dosage
    teriparatide -

    ATC: H05AA02

  • Oyavas is used for the treatment of several types of cancer in adults, including colorectal cancer (colon or rectum), metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, advanced primary ovarian, fallopian tube, or peritoneal cancer, and cervical cancer.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    bevacizumab -

    ATC: L01FG01

  • Tofidence is used to treat adults with moderate to severe active rheumatoid arthritis (RA) when previous therapies have not been sufficient. It is also indicated for adults with severe, active, and progressive rheumatoid arthritis not previously treated with methotrexate, for children over 2 years of age with systemic juvenile idiopathic arthritis (sJIA) or polyarticular juvenile idiopathic arthritis (pJIA), and for adults with COVID-19 who require oxygen therapy or mechanical ventilation and are receiving corticosteroid therapy.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    tocilizumab -

    ATC: L04AC07

  • Usgena is used for the treatment of several inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), moderate to severe Crohn's disease (in adults), and moderate to severe ulcerative colitis (in adults).

    Dosage form: solution for injection

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

  • Uzpruvo is used for the treatment of certain inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults and children weighing at least 40 kg).

    Dosage form: solution for injection in pre-filled syringe

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

  • It is used in adults to treat various eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and retinal vein occlusion (RVO).

    Dosage form: solution for injection

    Active substance Dosage
    ranibizumab -

    ATC: S01LA04